eMurmur Heart AI vs ElucidVivo A.3

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eMurmur Heart AI

by eMurmur

ElucidVivo A.3

by Elucid

AI Verdict

Tool A specializes in automated analysis of heart and lung sounds for detecting murmurs and providing hemodynamic insights, primarily using auscultation data. Tool B, however, focuses on quantitative analysis of arterial plaque composition and stability from CT angiography images to assist in atherosclerosis patient stratification. While both are FDA-cleared AI tools for cardiovascular care, their distinct input data (sounds vs. medical images) and analytical objectives make them suitable for different diagnostic and monitoring applications.

Choose eMurmur Heart AI if…

Choose eMurmur Heart AI if your primary need is real-time or remote automated analysis of heart and lung sounds for early detection, screening, and ongoing monitoring of cardiac and pulmonary conditions. This tool is ideal for clinicians seeking to enhance auscultation accuracy, facilitate telehealth consultations, and track changes in patient heart and lung sounds over time.

View eMurmur Heart AI →

Choose ElucidVivo A.3 if…

Choose ElucidVivo A.3 if your focus is on advanced, quantitative analysis of arterial plaque composition and stability from CT angiography images to better stratify atherosclerosis patients. This system is best suited for cardiologists, radiologists, and vascular surgeons who require detailed visualization and measurement of plaque characteristics to optimize treatment decisions and assess cardiovascular risk.

View ElucidVivo A.3 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eMurmur Heart AI	ElucidVivo A.3
Pricing	Contact for quote	Unknown
Deployment	Web-based, Mobile App, API integration	Cloud and on-premise secure deployment.
BAA Available	Yes AI-estimated	Unknown
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eMurmur Heart AI

eMurmur Heart AI offers broad accessibility through mobile apps (iOS, Android) and a web portal, along with hardware-neutral and stethoscope-agnostic compatibility. This provides greater flexibility and ease of integration into various clinical workflows and telehealth scenarios compared to ElucidVivo A.3's likely specialized software application deployment.

Clinical Value

ElucidVivo A.3

ElucidVivo A.3 provides highly detailed, quantitative analysis of arterial plaque composition and stability from CT angiography, including quantification of Lipid-Rich Necrotic Core (LRNC) and derivation of fractional flow reserve (FFRct), validated against histology. This offers a more advanced and specific diagnostic capability for atherosclerosis patient stratification and treatment optimization compared to eMurmur Heart AI's broader auscultation analysis.

Pricing & Value

Tie

Both tools require contacting the vendor for pricing information, making it impossible to compare their cost-effectiveness or overall value proposition. Without transparent pricing or detailed ROI studies, a definitive winner cannot be determined.

Enterprise Readiness

eMurmur Heart AI

eMurmur Heart AI explicitly states FDA clearance, HIPAA compliance, and the availability of a Business Associate Agreement (BAA). While ElucidVivo A.3 is FDA-cleared and implies HIPAA compliance, the explicit confirmation of BAA and HIPAA for Tool A provides greater assurance for enterprise adoption and regulatory compliance.

Innovation

ElucidVivo A.3

ElucidVivo A.3 demonstrates a higher degree of innovation by extracting highly granular, quantitative, and histologically validated insights into arterial plaque composition and stability from standard CT images. This represents a significant advancement in non-invasive cardiovascular risk assessment and treatment planning.

Support & Docs

Tie

The provided structured facts do not contain any information regarding the availability, quality, or scope of support and documentation for either eMurmur Heart AI or ElucidVivo A.3. Therefore, it is not possible to distinguish between the two tools on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eMurmur Heart AI	ElucidVivo A.3
Primary Function	Automated analysis of heart and lung sounds, detecting murmurs and providing hemodynamic insights.	Quantitative analysis of arterial plaque composition and stability from CT angiography.
Data Input/Modality	Digital stethoscopes, heart and lung sounds	CT angiography images
Key Outputs/Insights	Automated heart and lung sound analysis (S1, S2, murmurs, crackles, wheezes), detection and classification of pathologic and innocent heart murmurs, hemodynamic insights (loudness ratios of S1, systole, S2, diastole).	AI-powered quantitative analysis of arterial plaque, objectively quantifies Lipid-Rich Necrotic Core (LRNC), matrix, and calcifications from CT images, visualizes lesion-level plaque composition, provides 3D visualization of highlighted vessels, offers rotatable curved MPR vessel views and cross-sections, aids in stratifying patients with atherosclerosis, derives fractional flow reserve (FFRct) based on vessel wall vasodilative capacity.
Supported Specialties	Cardiology, Internal Medicine, Pulmonology	Cardiology, Radiology, Vascular Surgery
Company	CSD Labs	Elucid Bioimaging

Videos

Demos, reviews, and walkthroughs featuring eMurmur Heart AI and ElucidVivo A.3.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing clinical workflows for different cardiovascular conditions, and what specific patient populations benefit most from each?

eMurmur Heart AI integrates into point-of-care, telehealth, and remote auscultation workflows for screening and monitoring heart and lung sounds, benefiting patients needing early detection or ongoing assessment of murmurs. ElucidVivo A.3 integrates with PACS/EMR systems to analyze CT angiography images, aiding cardiologists, radiologists, and vascular surgeons in stratifying atherosclerosis patients and optimizing treatment decisions based on plaque characteristics.

What is the depth of EHR integration offered by each tool, and how does it streamline data flow for physician review and documentation?

eMurmur Heart AI offers a web portal for PDF report retrieval and integration into electronic patient files and hospital information systems, also supporting secure API integration into third-party systems. ElucidVivo A.3 integrates with PACS/EMR systems, which is standard for medical imaging software, allowing clinicians to access images and reports directly within the EHR for a comprehensive patient view.

What specific performance metrics (e.g., sensitivity, specificity) are available for each tool, and how were they validated?

eMurmur Heart AI has demonstrated sensitivity of 93% and specificity of 81% for pathologic murmur detection in a virtual clinical trial, and approximately 90% sensitivity and specificity against cardiologist interpretation and echocardiography. ElucidVivo A.3 provides quantitative plaque analysis validated against ground-truth histology and has shown high accuracy in estimating lesion-specific ischemia compared to invasive FFR.

What is the typical learning curve for physicians and staff to effectively use each tool, and what resources are available to facilitate adoption?

eMurmur Heart AI is described as having an easy-to-use interface with real-time quality assurance, suggesting a quick learning curve similar to standard auscultation. ElucidVivo A.3 involves intricate medical imaging analysis and detailed visualizations, which may imply a steeper learning curve, though its user interface follows typical clinical workflow patterns.

Beyond standard data security, what advanced security measures and audit-trail capabilities do these tools provide to ensure data integrity and accountability?

eMurmur Heart AI employs encrypted internet traffic, encrypted and duplicated backend data storage, and user authentication with no PHI on devices. ElucidVivo A.3 mentions SOC 2 / HIPAA-aligned data protection.

What kind of ongoing technical and clinical support is provided, and are there opportunities to connect with existing physician users for references or best practices?

eMurmur Heart AI offers general feedback and technical support via email and has partnered with academic institutions, with physician testimonials available. While specific support channels for ElucidVivo A.3 are not detailed, its use in leading health systems implies customer references.

For healthcare systems with multiple sites, what considerations or features do these tools offer to facilitate a smooth multi-site rollout and ensure consistent performance?

eMurmur Heart AI's mobile app, web portal, hardware-neutrality, and API integration provide flexibility for multi-site deployment. ElucidVivo A.3's PACS/EMR integration and cloud/on-premise deployment options are standard for enterprise-wide medical imaging software, supporting scalable implementation.